Urinary isoflavonoids and risk of coronary heart disease

International Journal of Epidemiology

Volumn 41, Issue 5, 2012, Pages 1367-1375

  Zhang, Xianglan ^a   Gao, Yu Tang ^b   Yang, Gong ^a   Li, Honglan ^b   Cai, Qiuyin ^a   Xiang, Yong Bing ^b   Ji, Bu Tian ^c   Franke, Adrian A ^d   Zheng, Wei ^a   Shu, Xiao Ou ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Coronary disease; Isoflavones; Soy foods

Indexed keywords

DAIDZEIN; EQUOL; GENISTEIN; GLYCITEIN; ISOFLAVONOID;

BIOACTIVITY; BIOMARKER; CARDIOVASCULAR DISEASE; FOOD CONSUMPTION; FOOD INTAKE; HEALTH RISK; LOGISTICS; METABOLISM; PUBLIC HEALTH; SOYBEAN;

ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SOYBEAN; URINE LEVEL;

ADULT; AGED; ALCOHOL DRINKING; BIOLOGICAL MARKERS; BODY WEIGHTS AND MEASURES; CHINA; CORONARY DISEASE; DIET; FEMALE; HUMANS; ISOFLAVONES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEX FACTORS; SMOKING; SOCIOECONOMIC FACTORS; SOY FOODS;

CHINA; SHANGHAI;

EID: 84867605310     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dys130     Document Type: Article

References (31)

1. US Food and Drug Adminisration. Food labeling: health claims: soy protein and coronary heart disease. Food and Drug Administration, HHS: final rule: soy protein and coronary heart disease. Fed Reg 1999;64:57700-33.
2. Anderson JW, Johnstone BM, Cook-Newell ME. Metaanalysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82.
3. Sacks FM, Lichtenstein A, Van Horn L et al. Soy protein, isoflavones, and cardiovascular health: an American heart association science advisory for professionals from the nutrition committee. Circulation 2006;113:1034-44.
4. He J, Gu D, Wu X et al. Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann Intern Med 2005;143:1-9.
5. Teede HJ, Giannopoulos D, Dalais FS, Hodgson J, McGrath BP. Randomised, controlled, cross-over trial of soy protein with isoflavones on blood pressure and arterial function in hypertensive subjects. J Am Coll Nutr 2006; 25:533-40.
6. Liu Zm, Chen Ym, Ho SC. Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2011;93:1092-101.
7. Pase MP, Grima NA, Sarris J. The effects of dietary and nutrient interventions on arterial stiffness: a systematic review. Am J Clin Nutr 2011;93:446-54.
8. Azadbakht L, Kimiagar M, Mehrabi Y et al. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 2007;85:735-41.
9. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC. Soy consumption, markers of inflammation, and endothelial function. Diabetes Care 2007;30: 967-73.
10. Kreijkamp-Kaspers S, Kok L, Bots ML, Grobbee DE, Lampe JW, van der Schouw YT. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr 2005;81:189-95.
11. Matthan NR, Jalbert SM, Ausman LM, Kuvin JT, Karas RH, Lichtenstein AH. Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr 2007;85: 960-66.
12. Li SH, Liu XX, Bai YY et al. Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am J Clin Nutr 2010;91: 480-86.
13. Beavers KM, Jonnalagadda SS, Messina MJ. Soy consumption, adhesion molecules, and pro-inflammatory cytokines: a brief review of the literature. Nutr Rev 2009;67:213-21.
14. Zhang X, Shu XO, Gao YT et al. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 2003;133:2874-78.
15. Kokubo Y, Iso H, Ishihara J et al. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan public health center based (JPHC) study cohort I. Circulation 2007;116:2553-62.
16. van der Schouw YT, Kreijkamp-Kaspers S, Peeters PHM, Keinan-Boker L, Rimm EB, Grobbee DE. Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in western women. Circulation 2005; 111:465-71.
17. Lissin LW, Cooke JP. Phytoestrogens and cardiovascular health. J Am Coll Cardiol 2000;35:1403-10.
18. Lampe JW. Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J Nutr 2003;133:956S-64S.
19. Franke AA, Halm BM, Kakazu K, Li X, Custer LJ. Phytoestrogenic isoflavonoids in epidemiologic and clinical research. Drug Test Analysis 2009;1:14-21.
20. Zheng W, Chow WH, Yang G et al. The Shanghai women's health study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005;162:1123-31.
21. Cai H, Zheng W, Xiang YB et al. Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai men's health study. Br J Nutr 2007;98:1006-13.
22. Rose GA, Blackburn H. Cardiovascular survey methods. In: WHO Monograph Series No. 58. Geneva. Switzerland: World Health Organization, 1982.
23. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-u'a clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132: 3577-84.
24. Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med 2005;230: 155-70.
25. Lampe JW. Is equol the key to the efficacy of soy foods? Am J Clin Nutr 2009;89:1664S-67S.
26. Setchell KDR, Cole SJ. Method of defining equolproducer status and its frequency among vegetarians. J Nutr 2006;136:2188-93.
27. Song KB, Atkinson C, Frankenfeld CL et al. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr 2006;136:1347-51.
28. Lampe JW, Fredstrom SB, Slavin JL, Potter JD. Sex differences in colonic function: a randomised trial. Gut 1993; 34:531-36.
29. Seow A, Shi CY, Franke AA, Hankin JH, Lee HP, Yu MC. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 1998;7:135-40.
30. Chen Z, Zheng W, Custer LJ et al. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 1999;33:82-87.
31. Frankenfeld CL, Atkinson C, Thomas WK et al. Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp Biol Med 2004;229:902-13.